Wikipedia -WSS

Wikipedia

author：focus 2025-10-01 06:01:35 - browse：3

Two hands hold a box of four Wegovy pens — first opinion coverage from STAT — Cydni Elledge/The New York Times

The news about anti-obesity drugs keeps getting better. In November, data presented at the American Heart Association meeting added cardiovascular benefit to value in combating obesity and diabetes. This comes on the heels of news that Novo Nordisk halted a clinical trial to test Wegovy’s impact on renal function early because the results they were seeing were so strong.

Yet beneath the hype lies a real fear. Unless we reverse the rising tide of metabolic syndrome, Medicare will be crushed, with tens of millions of Americans having shorter, harder lives. The new drugs offer the first real chance to deploy at scale treatments to halt a seemingly unstoppable trend.

That will be costly. But so is the status quo. Medicare spending on people with advanced metabolic disease is sobering. Beneficiaries with two or more of the costliest conditions — diabetes, heart failure, or chronic kidney disease — comprise just 10% of beneficiaries, according to the NIH’s Renal Data System 2022 Annual Data Report. Yet they account for 25% of total costs. Those with all three conditions are 2% of beneficiaries but almost 7% of costs. And remember, the current cohort of Medicare beneficiaries turned 65 when obesity and diabetes rates were lower, meaning unless we do something dramatic, and fast, these percentages will balloon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Can food be medicine? And other questions about a new push

Wikipedia

hotspot

WSS

David Sabatini, ex

Brain 'hot spot' may explain why African Americans feel greater pain

Inside the fall of star MIT scientist David Sabatini

Make 'food is medicine' a key part of White House nutrition meeting

Biohaven protein

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

hotspot

Wikipedia

explore

The high cost of giving birth even with insurance

A new study asks: Are we harming blood donors by taking blood?

Guidelines to prevent youth baseball injuries need more muscle

Report: NIH

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Australia's humpback populations rebound raising hopes of marine scientists

Cancer drug shortages should be causing more outrage

Stigma and the return of syphilis

Drug repurposing or repositioning? The language matters

Insmed lung disease drug hits target in key Phase 3 trial

hotspot

Inside the fall of star MIT scientist David Sabatini

Make 'food is medicine' a key part of White House nutrition meeting

Report: NIH

PhRMA sues HHS over Medicare drug price negotiation

Community addresses injustice for Long Island mothers

RaDonda Vaught case: a double standard for nurses, physicians

focus

Wikipedia

hotspot

entertainment